Gut Microbiota and Microbial Metabolites in Central Precocious Puberty: A Narrative Review
Microorganisms · 18.11.2026 · 14 (11) · 2682
DOI: 10.3390/microorganisms14112682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 18.11.2026. Verfasst von Shuhan Liu und 8 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ji Nan Health High-Caliber Talent Project.
Abstract (Originalsprache)
Central precocious puberty (CPP) is traditionally attributed to premature activation of the hypothalamic–pituitary–gonadal (HPG) axis, but emerging evidence implicates metabolic, inflammatory, environmental, and microbial factors. Here, we summarize human and experimental evidence linking the gut microbiota and its metabolites to CPP and discuss their translational potential. The available evidence is heterogeneous and includes studies of clinically diagnosed CPP, other pubertal phenotypes, and experimental models. Findings from physiological puberty, peripheral precocious puberty, and obesity-associated pubertal advancement provide indirect biological insights but should not be considered equivalent to direct clinical evidence of CPP. Children with CPP show altered microbial composition and function, although taxonomic signatures vary with age, adiposity, diet, geography, and analytical methods. Short-chain fatty acids, bile acids, tryptophan-derived metabolites, and estrogen-related microbial metabolism may connect intestinal ecology with host metabolism, immune signaling, and the KNDy–kisspeptin–GnRH network. However, most human studies remain cross-sectional, and multi-omics, mediation, or Mendelian randomization (MR) analyses cannot establish specific microbial–metabolite causal pathways. Experimental studies provide stronger mechanistic evidence through microbial perturbation, metabolite administration, and microbiota-directed interventions. We propose that microbiome and metabolite profiles should complement, rather than replace, conventional endocrine assessment and GnRH agonist therapy. Future studies should prioritize longitudinal multicenter cohorts, standardized multi-omics, causal perturbation, and randomized trials to determine whether microbiome-directed strategies improve outcomes beyond endocrine suppression.
Förderung
- Ji Nan Health High-Caliber Talent Project
Zitieren
APA
Liu, S., Liu, X., Zhang, Z., Li, L., Meng, J., He, N., Li, S., Liu, Y., & Li, N. (2026). Gut Microbiota and Microbial Metabolites in Central Precocious Puberty: A Narrative Review. Microorganisms, 14(11), 2682. https://doi.org/10.3390/microorganisms14112682
Vancouver
Liu S, Liu X, Zhang Z, Li L, Meng J, He N, et al. Gut Microbiota and Microbial Metabolites in Central Precocious Puberty: A Narrative Review. Microorganisms. 2026;14(11):2682. doi:10.3390/microorganisms14112682
BibTeX
@article{Liu2026,
author = {Liu, Shuhan and Liu, Xueying and Zhang, Ziheng and Li, Longyu and Meng, Jinshu and He, Ningning and Li, Shangyong and Liu, Yanan and Li, Ning},
title = {Gut Microbiota and Microbial Metabolites in Central Precocious Puberty: A Narrative Review},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2682},
doi = {10.3390/microorganisms14112682}
}
EUVIMED